ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting (updated 13 May 2014)

To experience the full functionality of the ISDA website, it is necessary to enable Javascript in your browser.
Here are instructions on how to enable JavaScript in your web browser.

Data & Reporting

May 13, 2014

ISDA and BBA joint letter to ESMA and National Competent Authorities (NCAs) providing an update on anticipated challenges for EMIR reporting of OTC Derivatives.

Documents (5) for ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting (updated 13 May 2014)

challenges-for-emir-reporting-post-go-live-update-final(pdf) will open in a new tab or window
appendix-2a(pdf) will open in a new tab or window
appendix-3b(pdf) will open in a new tab or window
appendix-3a(pdf) will open in a new tab or window
appendix-2b(pdf) will open in a new tab or window

ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting (updated 13 May 2014)

Documents (5) for ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting (updated 13 May 2014)

Related Articles